1. Home
  2. Browse
  3. HRA000524
HRA000524
   HRA000524.xlsx
Title:
Ratio of the interferon-gamma signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
Release date:
2021-01-04
Description:
Ratio of the interferon-gamma signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
Data Accessibility:   
Controlled access Request Data
BioProject:
PRJCA004143
Study type:
Disease Study
Disease name:
melanoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
HDAC000358
DAC name:
ims_gene_signature
Contact person:
Yu Rongshan
Email:
rsyu@xmu.edu.cn
Description:
Ratio of the interferon-gamma signature to the immunosuppression signature predicts anti-PD-1 therapy response in melanoma
Individuals & samples
Files
Request Data
Submitter:   Yu Rongshan / rsyu@xmu.edu.cn
Organization:   Xiamen University
Submission date:   2020-09-18
Requests:   14